Detalles de la búsqueda
1.
Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.
Tumour Biol
; 33(6): 2401-9, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22965881
2.
Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy.
Tumour Biol
; 33(1): 33-40, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21931992
3.
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients.
BMC Cancer
; 11: 202, 2011 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-21615953
4.
DNase is a prognostic marker in liver cancer patients receiving transarterial chemoembolization therapy.
Int J Clin Pharmacol Ther
; 51(1): 80-3, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23260008
5.
Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
Expert Opin Biol Ther
; 12 Suppl 1: S217-24, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22620489
Resultados
1 -
5
de 5
1
Próxima >
>>